Congress boosts fraud-fighting budgets for Medicare, Medicaid, and CHIP.
H.R. 10348 — Health Care Fraud Prevention and Enforcement Act · Filed by Thomas Suozzi (D-NY) · 1 cosponsor · Introduced Sep 10, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill increases federal funding for Medicare and Medicaid fraud detection and prosecution from 2027–2029 and beyond, directing money to the Departments of Health and Human Services and Justice, the FBI, and the Medicare Integrity Program. It expands the HHS Inspector General's authority to investigate fraud across Medicare, Medicaid, and ACA programs, clarifies that fraud-prevention activities can include public communication, and requires the GAO to study whether these programs are actually effective at reducing fraud.
Why we flagged it
The bill's core mechanism is straightforward: it appropriates additional federal funds to existing fraud-detection and prosecution agencies (HHS, DOJ, FBI) and expands investigative scope. This is a public-integrity measure, not a tax cut, subsidy, or deregulation.
What the text implies
- The bill requires a GAO study on program effectiveness but does not mandate action if the study finds the programs are ineffective—creating a potential accountability gap if fraud-prevention spending is not delivering measurable results.
- Expansion of HHS OIG authority to ACA programs (title I) may increase scrutiny of health insurance subsidies and marketplace fraud, potentially affecting beneficiaries' eligibility determinations if fraud is detected retroactively.
The full analysis lists 3 implications of this text.
Who stands to gain
federal law enforcement agencies (DOJ, FBI, HHS OIG); Medicare Integrity Program contractors